Adefovir dipivoxil Resistance

Adefovir Add-on Therapy after Emergence of Lamivudine Resistance Is Effective and Unlikely to Result in Resistance to Adefovir in HIV-HBV Coinfected Patients - 11/16/05

Treatment with Tenofovir Results in a Rapid Decrease of HBV-DNA Viral Load in Patients with Resistance or Sub-optimal Response to Adefovir - 11/16/05

Tenofovir Appears Highly Effective as Salvage Therapy for HBV Patients with Suboptimal Response to Adefovir - 11/16/05

Epivir-HBV Resistance

In Comparison to Adefovir, the Efficacy of Tenofovir Seems Unchanged by the Presence of Lamivudine-resistant HBV - 11/23/05

First Line Combination Therapy for Chronic Hepatitis B in HBV-HIV Coinfected Patients with Tenofovir Plus Lamivudine versus Sequential Treatment with Tenofovir Monotherapy after Lamivudine Failure - 11/21/05

Adefovir Add-on Therapy after Emergence of Lamivudine Resistance Is Effective and Unlikely to Result in Resistance to Adefovir in HIV-HBV Coinfected Patients - 11/16/05

A Cost-Effectiveness Analysis of Treatment Alternatives for Hepatitis B Cirrhosis - 11/16/05

Treatment with Tenofovir Results in a Rapid Decrease of HBV-DNA Viral Load in Patients with Resistance or Sub-optimal Response to Adefovir - 11/16/05

Tenofovir Appears Highly Effective as Salvage Therapy for HBV Patients with Suboptimal Response to Adefovir - 11/16/05

Entecavir Two-Year Resistance Update - 11/16/05


HBV Resistance

Antiviral Response and Resistance Surveillance for HBeAg-negative Patients in a Study Evaluating Emtricitabine Plus Clevudine versus Emtricitabine Monotherapy - 11/21/05

<--- Return to the 56th AASLD Main Page